HeartSciences Inc.
HSCS
$2.05
-$0.02-0.97%
NASDAQ
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 59.66% | -4.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 31.49% | -7.08% | |||
| Operating Income | -31.49% | 6.97% | |||
| Income Before Tax | -38.57% | 15.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -38.57% | 15.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -38.57% | 15.55% | |||
| EBIT | -31.49% | 6.97% | |||
| EBITDA | -31.61% | 6.99% | |||
| EPS Basic | -39.47% | 25.74% | |||
| Normalized Basic EPS | -39.45% | 25.74% | |||
| EPS Diluted | -39.47% | 25.74% | |||
| Normalized Diluted EPS | -39.45% | 25.74% | |||
| Average Basic Shares Outstanding | -0.65% | 13.73% | |||
| Average Diluted Shares Outstanding | -0.65% | 13.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||